The DOI matches its Crossref record; 376 of the 376 references it cites were found in a registry or an index.
Advances in the Treatment of Prolactinomas
Abstract
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of hyperprolactinemia and control of tumor mass. Medical therapy with dopamine agonists is highly effective in the majority of cases and represents the mainstay of therapy. Recent data indicating successful withdrawal of these agents in a subset of patients challenge the previously held concept that medical therapy is a lifelong requirement. Complicated situations, such as those encountered in resistance to dopamine agonists, pregnancy, and giant or malignant prolactinomas, may require multimodal therapy involving surgery, radiotherapy, or both. Progress in elucidating the mechanisms underlying the pathogenesis of prolactinomas may enable future development of novel molecular therapies for treatment-resistant cases. This review provides a critical analysis of the efficacy and safety of the various modes of therapy available for the treatment of patients with prolactinomas with an emphasis on challenging situations, a discussion of the data regarding withdrawal of medical therapy, and a foreshadowing of novel approaches to therapy that may become available in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ezzat, S., Zheng, L., Zhu, X.-F., Wu, G. E., & Asa, S. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14036 · Cited by 179
RetractedDopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Complexity and Diversity of Mammalian Adenylyl Cyclases
Sunahara, R. K., Dessauer, C. W., & Gilman, A. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002333 · Cited by 874
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Neve, K. A., Seamans, J. K., & Trantham‐Davidson, H. (2004) · Journal of Receptors and Signal Transduction · doi:10.1081/lrst-200029981 · Cited by 837
A Radioimmunoassay for Human Prolactin
Hwang, P., Guyda, H., & Friesen, H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1902 · Cited by 752
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea
Webster, J., Piscitelli, G., Polli, A., Ferrari, C. I., Ismail, I., & Scanlon, M. F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311403 · Cited by 699
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
Giros, B., Sokoloff, P., Martres, M.-P., Riou, J.-F., Emorine, L. J., & Schwartz, J.-C. (1989) · Nature · doi:10.1038/342923a0 · Cited by 685
Classical pituitary apoplexy: clinical features, management and outcome
Randeva, H. S., Schoebel, J., Byrne, J., Esiri, M., Adams, C. B. T., & Wass, J. A. H. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00754.x · Cited by 576
Galactorrhea: A Study of 235 Cases, Including 48 with Pituitary Tumors
Kleinberg, D. L., Noel, G. L., & Frantz, A. G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703172961103 · Cited by 560
PENICILUNASE-PRODUCING NEISSERIA GONORRH$OElig;q
ASHFORD, W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92467-3 · Cited by 557
Pollack, I. F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312207 · Cited by 556
The Role of Prolactin in Mammary Carcinoma
Clevenger, C. V., Furth, P. A., Hankinson, S. E., & Schuler, L. A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0036 · Cited by 545
Leber, K. A., Berglöff, J., & Pendl, G. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.1.0043 · Cited by 513
Barker, F. G., Klibanski, A., & Swearingen, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030461 · Cited by 506
Tolerance of cranial nerves of the cavernous sinus to radiosurgery
Tishler, R. B., Loeffler, J. S., Lunsford, L. D., Duma, C., Alexander, E., Kooy, H. M., & Flickinger, J. C. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90230-s · Cited by 486
Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Chambe, B., Montvernay, C., & Calender, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8145 · Cited by 483
Prolactin-Secreting Tumors and Hypogonadism in 22 Men
Carter, J. N., Tyson, J. E., Tous, G., Van Vliet, S., Faiman, C., & Friesen, H. G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810192991602 · Cited by 479
THE PREPARATION, IDENTIFICATION AND ASSAY OF PROLACTIN—A HORMONE OF THE ANTERIOR PITUITARY
Riddle, O., Bates, R. W., & Dykshorn, S. W. (1933) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1933.105.1.191 · Cited by 478
Adenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1118 · Cited by 472
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
Verhelst, J., Abs, R., Maiter, D., van den Bruel, A., Vandeweghe, M., Velkeniers, B., Mockel, J., Lamberigts, G., Petrossians, P., Coremans, P., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5810 · Cited by 449
Hypopituitarism Following External Radiotherapy for Pituitary Tumours in Adults
LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., AHMED, S. R., APPLEGATE, G., & SUTTON, M. L. (1989) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068308 · Cited by 444
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90191-6 · Cited by 444
Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas
Zhang, X. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.761 · Cited by 440
MOLITCH, M. E., ELTON, R. L., BLACKWELL, R. E., CALDWELL, B., CHANG, R. J., JAFFE, R., JOPLIN, G., ROBBINS, R. J., TYSON, J., & THORNER, M. O. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-698 · Cited by 435
Self-citationThe pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
Kelly, M. A., Rubinstein, M., Asa, S. L., Zhang, G., Saez, C., Bunzow, J. R., Allen, R. G., Hnasko, R., Ben-Jonathan, N., Grandy, D. K., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80351-7 · Cited by 426
Minniti, G., Traish, D., Ashley, S., Gonsalves, A., & Brada, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1152 · Cited by 377
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action1
Grumbach, M. M., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6290 · Cited by 368
Apfel, S. C., Schwartz, S., Adornato, B. T., Freeman, R., Biton, V., Rendell, M., Vinik, A., Giuliani, M., Stevens, J. C., Barbano, R., et al. (2000) · JAMA · doi:10.1001/jama.284.17.2215 · Cited by 368
Decreased Bone Density in Hyperprolactinemic Women
Klibanski, A., Neer, R. M., Beitins, I. Z., Ridgway, E. C., Zervas, N. T., & McArthur, J. W. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012253032605 · Cited by 360
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., & Lombardi, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022657 · Cited by 336
Self-citationPituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging
GONZALEZ, J., ELIZONDO, G., SALDIVAR, D., NANEZ, H., TODD, L., & VILLARREAL, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90542-6 · Cited by 335
Diagnosis and Management of Pituitary Carcinomas
Kaltsas, G. A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., & Grossman, A. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2231 · Cited by 325
Surgery during pregnancy and fetal outcome
Brodsky, J. B., Cohen, E. N., Brown, B. W., Wu, M. L., & Whitcher, C. E. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32785-5 · Cited by 315
Mechanisms of signal transduction at the dopamine D2 receptor
Vallar, L., & Meldolesi, J. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90082-5 · Cited by 312
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases
Sibal, L., Ball, S. G., Connolly, V., James, R. A., Kane, P., Kelly, W. F., Kendall-Taylor, P., Mathias, D., Perros, P., Quinton, R., et al. (2004) · Pituitary · doi:10.1007/s11102-005-1050-3 · Cited by 309
Results of Transsphenoidal Surgery in a Large Series of Patients with Pituitary Adenoma
Mortini, P., Losa, M., Barzaghi, R., Boari, N., & Giovanelli, M. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159647.64275.9d · Cited by 305
Age‐related and gender‐related occurrence of pituitary adenomas
Mindermann, T., & Wilson, C. B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02557.x · Cited by 304
Zada, G., Kelly, D. F., Cohan, P., Wang, C., & Swerdloff, R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.2.0350 · Cited by 302
Serri, O., Rasio, E., Beauregard, H., Hardy, J., & Somma, M. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090505 · Cited by 301
Somatostatin Analogs in Acromegaly
Freda, P. U. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3013 · Cited by 298
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action
Grumbach, M. M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4677 · Cited by 298
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U. (2003) · Movement Disorders · doi:10.1002/mds.10417 · Cited by 295
Fillat, C., Carrio, M., Cascante, A., & Sangro, B. (2003) · Current Gene Therapy · doi:10.2174/1566523033347426 · Cited by 287
The Epidemiology of Prolactinomas
Ciccarelli, A., Daly, A. F., & Beckers, A. (2005) · Pituitary · doi:10.1007/s11102-005-5079-0 · Cited by 286
An integrated logistic formula for prediction of complications from radiosurgery
Flickinger, J. C. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90082-5 · Cited by 286
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
Delgrange, E., Trouillas, J., Maiter, D., Donckier, J., & Tourniaire, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4088 · Cited by 277
A Region of Adenylyl Cyclase 2 Critical for Regulation by G Protein βγ Subunits
Chen, J., DeVivo, M., Dingus, J., Harry, A., Li, J., Sui, J., Carty, D. J., Blank, J. L., Exton, J. H., Stoffel, R. H., et al. (1995) · Science · doi:10.1126/science.7761832 · Cited by 277
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment
Colao, A. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.876 · Cited by 276
Self-citationThe Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*
SCHLECHTE, J., DOLAN, K., SHERMAN, B., CHAPLER, F., & LUCIANO, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-412 · Cited by 271
Resistance to Bromocriptine in Prolactinomas
PELLEGRINI, I., RASOLONJANAHARY, R., GUNZ, G., BERTRAND, P., DELIVET, S., JEDYNAK, C. P., KORDON, C., PEILLON, F., JAQUET, P., & ENJALBERT, A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-500 · Cited by 267
Colao, A., Sarno, A., Cappabianca, P., Briganti, F., Pivonello, R., Somma, C., Faggiano, A., Biondi, B., & Lombardi, G. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480325 · Cited by 267
Self-citationSheehan, J. P., Niranjan, A., Sheehan, J. M., Jane, J. A., Laws, E. R., Kondziolka, D., Flickinger, J., Landolt, A. M., Loeffler, J. S., & Lunsford, L. D. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.4.0678 · Cited by 262
Enjalbert, A., & Bockaert, J. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14305-8 · Cited by 262
Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119779 · Cited by 260
Colao, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., Zarrilli, S., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030979 · Cited by 256
Self-citationPregnancy and the Hyperprolactinemic Woman
Molitch, M. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505233122106 · Cited by 254
Self-citationDi Sarno, A., Landi, M. L., Cappabianca, P., Di Salle, F., Rossi, F. W., Pivonello, R., Di Somma, C., Faggiano, A., Lombardi, G., & Colao, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8054 · Cited by 247
Self-citationGiant pituitary tumors: a study based on surgical treatment of 118 cases
Goel, A. H., Nadkarni, T., Muzumdar, D., Desai, K. I., Phalke, U., & Sharma, P. (2004) · Surgical Neurology · doi:10.1016/j.surneu.2003.08.036 · Cited by 243
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
Horvath, J., Fross, R. D., Kleiner‐Fisman, G., Lerch, R., Stalder, H., Liaudat, S., Raskoff, W. J., Flachsbart, K. D., Rakowski, H., Pache, J., et al. (2004) · Movement Disorders · doi:10.1002/mds.20201 · Cited by 243
Growth-hormone and prolactin excess
Colao, A., & Lombardi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03356-x · Cited by 243
Self-citationDrugs Five Years Later: Bromocriptine
VANCE, M. L., EVANS, W. S., & THORNER, M. O. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-78 · Cited by 242
Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson, D. J. W., Hibberts, N. A., McNicol, A. M., Clayton, R. N., & Farrell, W. E. (2000) · PubMed · Cited by 236
FORBES, A. P., HENNEMAN, P. H., GRISWOLD, G. C., & ALBRIGHT, F. (1954) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-14-3-265 · Cited by 231
Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging.
Elster, A. D., Sanders, T. G., Vines, F. S., & Chen, M. Y. (1991) · Radiology · doi:10.1148/radiology.181.2.1924800 · Cited by 230
Colao, A., Di Sarno, A., Landi, M. L., Scavuzzo, F., Cappabianca, P., Pivonello, R., Volpe, R., Di Salle, F., Cirillo, S., Annunziato, L., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6657 · Cited by 227
Self-citationGreenman, Y., Tordjman, K., & Stern, N. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00403.x · Cited by 227
Valvular Heart Disease in Patients Taking Pergolide
Pritchett, A. M., Morrison, J. F., Edwards, W. D., Schaff, H. V., Connolly, H. M., & Espinosa, R. E. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.12.1280 · Cited by 222
Somatostatin receptor subtype gene expression in pituitary adenomas
Miller, G. M. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1386 · Cited by 220
Thyroid Nodules: Thyroid Cancer
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90134-5 · Cited by 220
Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factors
Tsang, R. W., Brierley, J. D., Panzarella, T., Gospodarowicz, M. K., Sutcliffe, S. B., & Simpson, W. J. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90941-a · Cited by 216
Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline
Biller, B. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.6.2338 · Cited by 216
H-ras mutations in human pituitary carcinoma metastases
Pei, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.4.842 · Cited by 216
Onesti, S. T., Wisniewski, T., & Post, K. D. (1990) · Neurosurgery · doi:10.1227/00006123-199006000-00010 · Cited by 215
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas
Fedele, M., Battista, S., Kenyon, L., Baldassarre, G., Fidanza, V., Klein-Szanto, A. J. P., Parlow, A. F., Visone, R., Pierantoni, G. M., Outwater, E., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205428 · Cited by 215
The incidence of cerebrovascular accidents in patients with pituitary adenoma
Brada, M., Burchell, L., Ashley, S., & Traish, D. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00159-5 · Cited by 210
Mitsumori, M., Shrieve, D. C., Alexander, E., Kaiser, U. B., Richardson, G. E., Black, P. M., & Loeffler, J. S. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00256-9 · Cited by 208
Pattern of increase in circulating prolactin levels during human gestation
Rigg, L. A., Lein, A., & Yen, S. S. C. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90594-4 · Cited by 207
Outcome of Pregnancy in Women with Pituitary Adenoma
Wallach, E., Gemzell, C., & Wang, C. F. (1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)43929-4 · Cited by 206
Visual Recovery after Transsphenoidal Removal of Pituitary Adenomas
Cohen, A. R., Cooper, P. R., Kupersmith, M. J., Flamm, E. S., & Ransohoff, J. (1985) · Neurosurgery · doi:10.1227/00006123-198509000-00008 · Cited by 206
Increase in Bone Mass after Treatment of Hyperprolactinemic Amenorrhea
Klibanski, A., & Greenspan, S. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150903 · Cited by 205
Höybye, C., Grenbäck, E., Rähn, T., Degerblad, M., Thorén, M., & Hulting, A.-L. (2001) · Neurosurgery · doi:10.1097/00006123-200108000-00008 · Cited by 200
Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists
Goffin, V., Bernichtein, S., Touraine, P., & Kelly, P. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0016 · Cited by 199
Pharmacologic Resistance in Prolactinoma Patients
Molitch, M. E. (2005) · Pituitary · doi:10.1007/s11102-005-5085-2 · Cited by 194
Self-citationPollock, B. E., Nippoldt, T. B., Stafford, S. L., Foote, R. L., & Abboud, C. F. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.3.0525 · Cited by 193
Senogles, S. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31628-9 · Cited by 191
Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*
Thorner, M. O., PERRYMAN, R. L., Rogol, A. D., CONWAY, B. P., MacLeod, R. M., Login, I. S., & Morris, J. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-3-480 · Cited by 191
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.3.724 · Cited by 190
Prolactinomas in Children and Adolescents. Clinical Presentation and Long-Term Follow-Up
Colao, A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2777 · Cited by 189
Self-citationWebster, J. (1996) · Drug Safety · doi:10.2165/00002018-199614040-00003 · Cited by 186
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
Panetta, R., & Patel, Y. C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00956-2 · Cited by 185
Conservative management of pituitary apoplexy: a prospective study.
Maccagnan, P., Macedo, C. L., Kayath, M. J., Nogueira, R. G., & Abucham, J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608278 · Cited by 183
Surgical Treatment of Prolactin-Secreting Pituitary Adenomas: Early Results and Long-Term Outcome
Losa, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3180 · Cited by 181
Temozolomide: a novel treatment for pituitary carcinoma
Lim, S., Shahinian, H., Maya, M. M., Yong, W., & Heaney, A. P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70728-8 · Cited by 181
Functional role of estrogen in pituitary tumor pathogenesis
Heaney, A. P., Fernando, M., & Melmed, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14264 · Cited by 181
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study
Delgrange, E. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2102 · Cited by 181
Asa, S. L., Kelly, M. A., Grandy, D. K., & Low, M. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7118 · Cited by 180
Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
Greenman, Y. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.398 · Cited by 180
Pregnancy outcome after treatment with the ergot derivative, cabergoline
Robert, E., Musatti, L., Piscitelli, G., & Ferrari, C. I. (1996) · Reproductive Toxicology · doi:10.1016/0890-6238(96)00063-9 · Cited by 178
Prolactin as an autocrine/paracrine growth factor in human cancer
Ben-Jonathan, N., Liby, K., McFarland, M., & Zinger, M. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00603-3 · Cited by 177
Páez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A. C., Hopfner, U., Grübler, Y., Chervin, A., Goldberg, V., Goya, R., Hentges, S. T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237312100 · Cited by 174
Caccavelli, L., Feron, F., Morange, I., Rouer, E., Benarous, R., Dewailly, D., Jaquet, P., Kordon, C., & Enjalbert, A. (1994) · Neuroendocrinology · doi:10.1159/000126764 · Cited by 173
Pituitary dimensions and volume measurements in pregnancy and post partum: MR assessment
Dinç, H., Esen, F., Demirci, A., Sari, A., & Gümele, H. R. (1998) · Acta Radiologica · doi:10.1080/02841859809172152 · Cited by 172
MEDICAL TREATMENT OF PROLACTINOMAS
Molitch, M. E. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70061-x · Cited by 171
Self-citationBakker, K., Sluiter, W. J., Doorenbos, H., & Woldring, M. G. (1976) · The Lancet · doi:10.1016/s0140-6736(76)99037-1 · Cited by 170
Hypopituitarism After External Irradiation: Evidence for Both Hypothalamic and Pituitary Origin
SAMAAN, N. A., BAKDASH, M. M., CADERAO, J. B., CANGIR, A., JESSE, R. H., & BALLANTYNE, A. J. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-6-771 · Cited by 168
Hypopituitarism following radiation therapy of pituitary adenomas
Snyder, P. J., Fowble, B. F., Schatz, N. J., Savino, P. J., & Gennarelli, T. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90299-8 · Cited by 167
Giant prolactinomas: clinical management and long-term follow up
Shrivastava, R. K., Arginteanu, M. S., King, W. A., & Post, K. D. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.2.0299 · Cited by 165
Long-Term and Low-Dose Treatment with Cabergoline Induces Macroprolactinoma Shrinkage
Colao, A., Di Sarno, A., Landi, M. L., Cirillo, S., Sarnacchiaro, F., Facciolli, G., Pivonello, R., Cataldi, M., Merola, B., Annunziato, L., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4368 · Cited by 163
Self-citationTranssphenoidal microsurgery for prolactin-secreting pituitary adenomas
Faria, M. A., & Tindall, G. T. (1982) · Journal of neurosurgery · doi:10.3171/jns.1982.56.1.0033 · Cited by 161
Primary Medical Therapy of Micro- and Macroprolactinomas in Men
Pinzone, J. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3053 · Cited by 161
Radiosurgery for Pituitary Tumors and Craniopharyngiomas
Laws, E. R., & Vance, M. L. (1999) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30198-0 · Cited by 161
External radiotherapy of pituitary adenomas
Zierhut, D., Flentje, M., Adolph, J., Erdmann, J., Raue, F., & Wannenmacher, M. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00071-6 · Cited by 158
Pregnancy outcome after cabergoline treatment in early weeks of gestation
Ricci, E. D., Parazzini, F., Motta, T., Ferrari, C. I., Colao, A., Clavenna, A., Rocchi, F., Gangi, E., Paracchi, S., Gasperi, M., et al. (2002) · Reproductive Toxicology · doi:10.1016/s0890-6238(02)00055-2 · Cited by 157
Self-citationColin, P., Jovenin, N., Delemer, B., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.058 · Cited by 157
Treatment of macroprolactinoma with cabergoline: a study of 85 patients
Ferrari, C. I., Abs, R., Bevan, J. S., Brabant, G. E., CICCARELLI, E., Motta, T., Mucci, M., Muratori, M., Musatti, L., Verbessem, G., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1300952.x · Cited by 154
Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic Correlations
Redfield, M. M., Nicholson, W. J., Edwards, W. D., & Tajik, A. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-50 · Cited by 154
Fagin, J. A. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05895 · Cited by 154
Radiation Therapy in the Multimodal Treatment Approach of Pituitary Adenoma
Becker, G., Köcher, M., Kortmann, R., Paulsen, F., Jeremic, B. M., Müller, R., & Bamberg, M. (2002) · Strahlentherapie und Onkologie · doi:10.1007/s00066-002-0826-x · Cited by 152
Bigazzi, M., Ronga, R., Lancranjan, I., FERRARO, S., Branconi, F., Buzzoni, P., Martorana, G., Scarselli, G., & del Pozo, E. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-1-9 · Cited by 151
Bromocriptine in pregnancy: Safety aspects
Krupp, P., & Monka, C. (1987) · Journal of Molecular Medicine · doi:10.1007/bf01727477 · Cited by 150
Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas
March, C. M., Kletzky, O. A., Davajan, V., Teal, J. S., Weiss, M., Apuzzo, M. L. J., Marrs, R. P., & Mishell, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90553-6 · Cited by 149
Giant prolactinomas in men: efficacy of cabergoline treatment
Corsello, S. M., Ubertini, G., Altomare, M., Lovicu, R. M., Migneco, M. G., Rota, C. A., & Colosimo, C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01770.x · Cited by 148
Transsphenoidal Microsurgical Therapy of Prolactinomas: Initial Outcomes and Long-term Results
Tyrrell, J., Lamborn, K. R., Hannegan, L. T., Applebury, C. B., & Wilson, C. B. (1999) · Neurosurgery · doi:10.1097/00006123-199902000-00006 · Cited by 148
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea
Biller, B. M. K., Baum, H. B. A., Rosenthal, D. I., SAXE, V. C., Charpie, P. M., & Klibanski, A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517356 · Cited by 146
Schuff, K. G., Hentges, S. T., Kelly, M. A., Binart, N., Kelly, P. A., Iuvone, P. M., Asa, S. L., & Low, M. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15912 · Cited by 146
Cabergoline in the long-term therapy of hyperprolactinemic disorders
Ferrari, C., PARACCHI, A., MATTEI, A. M., de Vincentiis, S., D'Alberton, A., & Crosignani, P. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1260489 · Cited by 146
Cyclin D and cyclin E expression in normal and adenomatous pituitary
Jordan, S., Lidhar, K., Korbonits, M., Lowe, D., & Grossman, A. B. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.143r001 · Cited by 146
LEYENDECKER, G., Struve, T. D., & Plotz, E. J. (1980) · Archives of Gynecology and Obstetrics · doi:10.1007/bf02108310 · Cited by 145
Rains, C. P., Bryson, H. M., & Fitton, A. (1995) · Drugs · doi:10.2165/00003495-199549020-00009 · Cited by 142
Visual Loss in Pregnant Women with Pituitary Adenomas
Kupersmith, M. J., Rosenberg, C., & Kleinberg, D. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00001 · Cited by 142
Dopamine receptor agonists for treating prolactinomas
Colao, A., Somma, C. D., Lombardi, G., Pivonello, R., & Sarno, A. D. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.787 · Cited by 141
Self-citationLow Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
Liuzzi, A., DALLABONZANA, D., OPPIZZI, G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509123131103 · Cited by 139
Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas
Cho, D., & Liau, W.-R. (2002) · Surgical Neurology · doi:10.1016/s0090-3019(02)00892-3 · Cited by 138
Preferential coupling between dopamine D2 receptors and G-proteins
Montmayeur, J., Guiramand, J., & Borrelli, E. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.2.7682286 · Cited by 138
Gamma Knife Radiosurgery for Pituitary Adenoma: Early Results
Petrovich, Z. P., Yu, C., Giannotta, S. L., Zee, C., & Apuzzo, M. L. J. (2003) · Neurosurgery · doi:10.1227/01.neu.0000068702.00330.47 · Cited by 137
Estrogen-Induced Prolactinoma in a Man
Gooren, L. J., Assies, J., Asscheman, H., Slegte, R. G. M. D., & van Kessel, H. I. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-444 · Cited by 136
Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function
Feigl, G. C., Bonelli, C. M., Berghold, A., et al. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0415 · Cited by 136
Prolactin: Evidence That It Is Separate from Growth Hormone in Human Blood
FRANTZ, A. G., & Kleinberg, D. L. (1970) · Science · doi:10.1126/science.170.3959.745 · Cited by 135
McAndrew, J., Paterson, A. J., Asa, S. L., McCarthy, K. J., & Kudlow, J. E. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664668 · Cited by 134
Surgical treatment of giant pituitary adenomas.
Symon, L., Jakubowski, J. J., & Kendall, B. E. (1979) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.42.11.973 · Cited by 133
High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
St‐Jean, E., Blain, F., & Comtois, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.663486.x · Cited by 133
Pituitary Tumors in Children and Adolescents
Lafferty, A. R. A., & Chrousos, G. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4317 · Cited by 132
Cannavò, S., Curtò, L., Squadrito, S., Almoto, B., Vieni, A., & Trimarchi, F. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03343573 · Cited by 131
Role of radiation therapy in clinical hormonally-active pituitary adenomas
Tsang, R. W. C., Brierley, J. D., Panzarella, T., et al. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91807-1 · Cited by 131
Gamma knife radiosurgery as a primary treatment for prolactinomas
Pan, L., Zhang, N., Wang, E. M., Wang, B. J., Dai, J. Z., & Cai, P. W. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.supplement_3.0010 · Cited by 130
Nonpuerperal galactorrhea and hyperprolactinemia
Gómez, F., Reyes, F. I., & Faiman, C. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90866-x · Cited by 129
Long‐term follow‐up of patients with hyperprolactinaemia
Jeffcoate, W. J., Pound, N., Sturrock, N. D. C., & Lambourne, J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00824.x · Cited by 129
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients
Muratori, M., Arosio, M., Gambino, G., et al. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348016 · Cited by 129
Pituitary adenomas in childhood and adolescence: Results of transsphenoidal surgery
Partington, M. D., Davis, D. H., Laws, E. R., & Scheithauer, B. W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.2.0209 · Cited by 128
Rosa, M. D., Colao, A. A. L., Sarno, A. D., Ferone, D., Landi, M. L., Zarrilli, S., Paesano, L., Merola, B., & Lombardi, G. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380286 · Cited by 127
Self-citationMarchant, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90103-8 · Cited by 127
Kovács, K., Ştefăneanu, L., Ezzat, S., & Smyth, H. S. (1994) · PubMed · Cited by 125
Molecular targets in pituitary tumours
Heaney, A. P., & Melmed, S. K. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1320 · Cited by 125
Mindermann, T., & Wilson, C. B. (1995) · Neurosurgery · doi:10.1227/00006123-199502000-00004 · Cited by 125
Sheehan, M. T., Atkinson, J. L. D., Kasperbauer, J. L., Erickson, B. J., & Nippoldt, T. B. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.7.661 · Cited by 123
Bronstein, M. D. (2005) · Pituitary · doi:10.1007/s11102-005-5083-4 · Cited by 123
Steger, R. W., Chandrashekar, V., Zhao, W., Bartke, A., & Horseman, N. D. (1998) · Endocrinology · doi:10.1210/endo.139.9.6209 · Cited by 122
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Turner, T. H., Cookson, J., Wass, J. A. H., Drury, P. L., Price, P. A., & Besser, G. M. (1984) · BMJ · doi:10.1136/bmj.289.6452.1101 · Cited by 122
Biswas, M., Smith, J., Jadon, D. R., McEwan, P. C., Rees, A., Evans, M., Scanlon, M. F., & Davies, J. S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02293.x · Cited by 122
Follow-Up of Children Born of Bromocriptine-Treated Mothers
Raymond, J. P., Goldstein, E., Konopka, P., Leleu, M. F., Merceron, R. E., & Loria, Y. (2008) · Hormone Research · doi:10.1159/000180100 · Cited by 120
Complications after trans-sphenoidal surgery: our experience and a review of the literature
Sudhakar, N., Ray, A. K., & Vafidis, J. A. (2004) · British Journal of Neurosurgery · doi:10.1080/02688690400012459a · Cited by 117
Kansra, S., Yamagata, S., Sneade, L., Foster, L. A., & Ben‐Jonathan, N. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.04.008 · Cited by 117
Bevan, J. S., ADAMS, C. B. T., Burke, C. W., MORTON, K. E., Molyneux, A., Moore, A., & Esiri, M. M. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00809.x · Cited by 117
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males
Di Somma, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.807 · Cited by 117
Gamma knife radiosurgery for pituitary adenomas
Izawa, M., Hayashi, M., Nakaya, K., et al. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.supplement_3.0019 · Cited by 117
The natural history of untreated microprolactinomas
Sisam, D. A., Sheehan, J. P., & Sheeler, L. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59292-9 · Cited by 116
Prolactin‐Secreting pituitary tumors
Antunes, J. L. F., Housepian, E. M., FRANTZ, A. G., Holub, D. A., Hui, R. M., Carmel, P. W., & Quest, D. O. (1977) · Annals of Neurology · doi:10.1002/ana.410020210 · Cited by 116
Four Years’ Experiences in the Treatment of Pituitary Adenomas with Gamma Knife Radiosurgery
Lim, Y., Leem, W., Kim, T. S., Rhee, B. A., & Kim, G. K. (1998) · Stereotactic and Functional Neurosurgery · doi:10.1159/000056412 · Cited by 116
Burgess, J. R., Shepherd, J. J., Parameswaran, V., Hoffman, L., & Greenaway, T. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675591 · Cited by 116
Heart valvular disease in patients with Parkinson’s disease treated with high-dose pergolide
Camp, G. V., Flamez, A., Cosyns, B., Goldstein, J. W., Perdaens, C., & Schoors, D. (2003) · Neurology · doi:10.1212/01.wnl.0000083985.00343.f2 · Cited by 115
Gamma Knife Radiosurgery for Pituitary Adenomas
Hayashi, M., Izawa, M., Hiyama, H., Nakamura, S., Atsuchi, S., Sato, H., Nakaya, K., Sasaki, K., Ochiai, T., Kubo, O., et al. (1999) · Stereotactic and Functional Neurosurgery · doi:10.1159/000056446 · Cited by 115
Stereotactic Radiosurgery for Pituitary Adenomas: A Review of the Literature
Laws, E. R., Sheehan, J. P., Sheehan, J. M., Jagnathan, J., Jane, J. A., & Oskouian, R. J. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000041887.51906.b7 · Cited by 113
Natural History of Microprolactinomas: Six-Year Follow-up
Weiss, M. H., Teal, J. S., Gott, P. S., Wycoff, R., Yadley, R. A., Apuzzo, M. L. J., Giannotta, S. L., Kletzky, O. A., & March, C. M. (1983) · Neurosurgery · doi:10.1227/00006123-198302000-00008 · Cited by 110
Pituitary Carcinoma: A Clinicopathological Review
Scheithauer, B. W., Yapıcıer, Ö., Kovács, K., Young, W. F., & Lloyd, R. V. (2005) · Neurosurgery · doi:10.1227/01.neu.0000157926.72826.db · Cited by 109
Perivascular Fibrosis in Prolactinomas: Is it Increased by Bromocriptine*
Landolt, A. M., & Osterwalder, V. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-6-1179 · Cited by 109
Radiosurgery for pituitary adenomas
Brada, M., Ajithkumar, T., & Minniti, G. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02138.x · Cited by 108
Verlaat, J. W. V., & CROUGHS, R. J. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00289.x · Cited by 108
Long-Term Follow-Up of Prolactinomas: Normoprolactinemia after Bromocriptine Withdrawal
Passos, V. Q., de Souza, J. J. S., Musolino, N. R. D. C., & Bronstein, M. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8722 · Cited by 107
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy
Schifitto, G., Yiannoutsos, C. T., Simpson, D. M., Adornato, B. T., Singer, E. J., Hollander, H., Marra, C. M., Rubin, M., Cohen, B. A., Tucker, T., et al. (2001) · Neurology · doi:10.1212/wnl.57.7.1313 · Cited by 106
Long-term Follow-up of Transsphenoidal Selective Adenomectomy for Prolactinoma
Rodman, E. F., Molitch, M. E., Post, K. D., Biller, B. J., & Reichlin, S. (1984) · JAMA · doi:10.1001/jama.1984.03350070039020 · Cited by 106
Self-citationPergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth Hormone
Kleinberg, D. L., BOYD, A. E., Wardlaw, S. L., FRANTZ, A. G., GEORGE, A. E., Bryan, R. N., HILAL, S. P., Greising, J., Hamilton, D. J., Seltzer, T. F., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309223091205 · Cited by 105
Megavoltage pituitary irradiation in the management of prolactinomas: long‐term follow‐up
Tsagarakis, S., Grossman, A. B., Plowman, P. N., et al. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00312.x · Cited by 105
Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery
Yoon, S., Suh, T. S., Jang, H.-S., et al. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00124-2 · Cited by 105
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy
Morange, I., Barlier, A., Pellegrini, I., Brue, T. C., Enjalbert, A., & Jaquet, P. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350413 · Cited by 104
The effect of the menopause on prolactin levels in patients with hyperprolactinaemia
Karunakaran, S., Page, R. C., & Wass, J. A. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01190.x · Cited by 104
EFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS
Johnston, D. G., Taylor, P. K., Watson, M., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90480-x · Cited by 103
Loss of vision after transsphenoidal surgery
Barrow, D. L., & Tindall, G. T. (1990) · Neurosurgery · doi:10.1097/00006123-199007000-00008 · Cited by 103
Forearm and Vertebral Bone Mineral in Treated and Untreated Hyperprolactinemic Amenorrhea*
Schlechte, J., El-Khoury, G. Y., Kathol, M. H., & Walkner, L. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1021 · Cited by 103
Cited by
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844
Diagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Self-citationWhat Can We Learn from Rodents about Prolactin in Humans?
Ben-Jonathan, N., LaPensee, C. R., & LaPensee, E. W. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0017 · Cited by 523
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Briet, C., Salenave, S., Bonneville, J.-F., Laws, E. R., & Chanson, P. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1042 · Cited by 409
Metadata
- Authors
- Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2006-05-26
- Volume
- 27
- Issue
- 5
- Pages
- 485-534
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2017283375
- Cited by
- 824
- References
- 376
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.